WASHINGTON, Aug 30 (Reuters) – Democrat Elizabeth Warren and
19 other U.S. senators voiced concern to the chief executive of
Mylan NV about the high cost of its EpiPen on Tuesday,
calling the device…
The post U.S. senators press Mylan on ‘exorbitantly expensive’ EpiPen appeared first on NASDAQ.